Intracranial hemangiopericytoma—our experience in 30 years: a series of 43 cases and review of the literature

AG Melone, A D'Elia, F Santoro, M Salvati, R Delfini… - World Neurosurgery, 2014 - Elsevier
Objective Meningeal hemangiopericytoma (HPC) is a rare, aggressive central nervous
system tumor that tends to invade locally and to metastasize, and has a high rate of …

Predictors of mortality following treatment of intracranial hemangiopericytoma

MJ Rutkowski, ME Sughrue, AJ Kane, D Aranda… - Journal of …, 2010 - thejns.org
Object Intracranial hemangiopericytoma (HPC) is a rare and malignant extraaxial tumor with
a high proclivity toward recurrence and metastasis. Given this lesion's rarity, little information …

Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor

MS Park, SR Patel, JA Ludwig, JC Trent, CA Conrad… - Cancer, 2011 - Wiley Online Library
BACKGROUND: Hemangiopericytomas and malignant solitary fibrous tumors (HPC/SFT)
are rare, closely related sarcomas with unpredictable behavior that respond infrequently to …

Hemangiopericytoma: long-term outcome revisited

M Schiariti, P Goetz, H El-Maghraby, J Tailor… - Journal of …, 2011 - thejns.org
Object Hemangiopericytomas are rare tumors that behave aggressively with a high rate of
local recurrence and distant metastases. With the aim of determining the outcome and …

Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients

MJ Rutkowski, BJ Jian, O Bloch, C Chen, ME Sughrue… - Cancer, 2012 - Wiley Online Library
INTRODUCTION: Intracranial hemangiopericytoma (HPC) is a malignant meningothelial
tumor. Because of its rarity, few guidelines exist for optimal management. METHODS …

Inhibiting the VEGF–VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor

MS Park, V Ravi, DM Araujo - Current opinion in oncology, 2010 - journals.lww.com
Current Opinion in Oncology Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …

New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of tumors

MS Park, DM Araujo - Current opinion in oncology, 2009 - journals.lww.com
With many novel targeted therapies currently in development for soft tissue sarcomas, a
better understanding of the molecular pathogenesis and aberrations of HPC/SFT is needed …

Clinical characteristics and outcomes for solitary fibrous tumor (SFT): a single center experience

N DeVito, E Henderson, G Han, D Reed, MM Bui… - PLoS …, 2015 - journals.plos.org
Solitary fibrous tumor (SFT) is a mesenchymal neoplasm of fibrous origin. The 2013 WHO
classification of soft tissue tumors defines malignant forms as hypercellular, mitotically active …

Extrameningeal solitary fibrous tumors—Surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative …

RL Haas, I Walraven, E Lecointe‐Artzner… - Cancer, 2020 - Wiley Online Library
Background Solitary fibrous tumor (SFT) is a rare mesenchymal malignancy. Although
surgery is potentially curative, the local relapse risk is high after marginal resections. Given …

Solitary-fibrous tumor/hemangiopericytoma of the central nervous system: a population-based study

CJ Kinslow, SS Bruce, AI Rae, SA Sheth… - Journal of Neuro …, 2018 - Springer
Abstract The World Health Organization (WHO) classification of tumors of the central
nervous system (CNS) was recently updated, restructuring solitary fibrous tumor (SFT) and …